BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinicrope FA. Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med 2022;386:1547-58. [PMID: 35443109 DOI: 10.1056/NEJMra2200869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Grabenbauer A, Aigner T, Göbel H, Leibl BJ, Lamberti C, Grabenbauer GG, Distel LV. Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions? Cells 2023;12:399. [DOI: 10.3390/cells12030399] [Reference Citation Analysis]
2 Furtak-niczyporuk M, Zardzewiały W, Balicki D, Bernacki R, Jaworska G, Kozłowska M, Drop B. Colorectal Cancer—The Worst Enemy Is the One We Do Not Know. IJERPH 2023;20:1866. [DOI: 10.3390/ijerph20031866] [Reference Citation Analysis]
3 Oliero M, Hajjar R, Cuisiniere T, Fragoso G, Calvé A, Dagbert F, Loungnarath R, Sebajang H, Schwenter F, Wassef R, Ratelle R, De Broux É, Richard CS, Santos MM. Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer. Gut Pathog 2022;14:51. [PMID: 36578036 DOI: 10.1186/s13099-022-00523-y] [Reference Citation Analysis]
4 Li D. Establishment and validation a prognostic nomogram for early-onset colon cancer patients in stage I-II.. [DOI: 10.21203/rs.3.rs-2389818/v1] [Reference Citation Analysis]
5 Ahmad A, Prakash R, Khan MS, Altwaijry N, Asghar MN, Raza SS, Khan R. Nanoparticle-Mediated PRDX2 Inhibition for Specific Targeting of CHK2-Null Colorectal Cancer. ACS Biomater Sci Eng 2022;8:5210-20. [PMID: 36446128 DOI: 10.1021/acsbiomaterials.2c01073] [Reference Citation Analysis]
6 AACR Cancer Progress Report 2022 Steering Committee. Cancer in 2022. Cancer Discov 2022;12:2733-8. [PMID: 36458429 DOI: 10.1158/2159-8290.CD-22-1134] [Reference Citation Analysis]
7 Han S, Chok AY, Peh DYY, Ho JZ, Tan EKW, Koo S, Tan IB, Ong JC. The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.933475] [Reference Citation Analysis]
8 Zhang Y, Zhang L, Li F, He J, Xuan J, Chen C, Gong C, Pan Y. PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/8394816] [Reference Citation Analysis]
9 Khan MA, Sahar N, Khan WZ, Alhaisoni M, Tariq U, Zayyan MH, Kim YJ, Chang B. GestroNet: A Framework of Saliency Estimation and Optimal Deep Learning Features Based Gastrointestinal Diseases Detection and Classification. Diagnostics 2022;12:2718. [DOI: 10.3390/diagnostics12112718] [Reference Citation Analysis]
10 Jiamei Jia, Mengmeng Wang, Shuqiao Xing, Zhihui Huang, Yuanyuan Jiang. Crosstalk between enteric serotonergic neurons and colorectal cancer stem cells to initiate colorectal tumorigenesis. Front Oncol 2022;12:1054590. [PMID: 36408175 DOI: 10.3389/fonc.2022.1054590] [Reference Citation Analysis]
11 Singh S, Gupta S. Promise and Perils of Blood-based Signatures for Detecting Early-Onset Colorectal Cancer. Gastroenterology 2022;163:1155-7. [PMID: 35961378 DOI: 10.1053/j.gastro.2022.08.011] [Reference Citation Analysis]
12 Greef B, Smyth E. Colorectal cancer. Medicine 2022. [DOI: 10.1016/j.mpmed.2022.10.014] [Reference Citation Analysis]
13 Garner WB, Smith BD, Ludmir EB, Wakefield DV, Shabason J, Williams GR, Martin MY, Wang Y, Ballo MT, VanderWalde NA. Predicting future cancer incidence by age, race, ethnicity, and sex. J Geriatr Oncol 2022;:101393. [PMID: 36692964 DOI: 10.1016/j.jgo.2022.10.008] [Reference Citation Analysis]
14 Xiong H, Wang J, Chang Z, Hu H, Yuan Z, Zhu Y, Hu Z, Wang C, Liu Y, Wang Y, Wang G, Tang Q. Gut microbiota display alternative profiles in patients with early-onset colorectal cancer. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1036946] [Reference Citation Analysis]
15 Montminy EM, Zhou M, Long C, Wani S, Patel SG, Karlitz JJ. Impact of Carcinoid and Appendiceal Site Inclusion on Early Onset Colon Cancer Incidence Rate Analysis in the United States. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00999-5. [PMID: 36273798 DOI: 10.1016/j.cgh.2022.10.010] [Reference Citation Analysis]
16 Nomogram for predicting the overall survival for young-onset colorectal cancer with liver metastases: a SEER database analysis.. [DOI: 10.21203/rs.3.rs-1924954/v2] [Reference Citation Analysis]
17 Jiang J, Lü M, Tang X. Prevalence of Young-Onset Colorectal Neoplasia: Time to Decrease the Starting Age for Screening? Gastroenterology 2022;163:1119-1119.e1. [PMID: 35550143 DOI: 10.1053/j.gastro.2022.05.008] [Reference Citation Analysis]
18 Marzo-Castillejo M, Bartolomé-Moreno C, Bellas-Beceiro B, Melús-Palazón E, Vela-Vallespín C. [PAPPS Expert Groups. Cancer prevention recommendations: Update 2022]. Aten Primaria 2022;54 Suppl 1:102440. [PMID: 36435580 DOI: 10.1016/j.aprim.2022.102440] [Reference Citation Analysis]
19 Duarte Mendes A, Vicente R, Vitorino M, Silva M, Alpuim Costa D. Modulation of tumor environment in colorectal cancer – could gut microbiota be a key player? Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.1021050] [Reference Citation Analysis]
20 Kommentar zu: Die Epidemiologie von Darmkrebs hat sich in den letzten Jahrzehnten verändert. Gastroenterologie up2date 2022;18:192-194. [DOI: 10.1055/a-1895-8017] [Reference Citation Analysis]
21 Die Epidemiologie von Darmkrebs hat sich in den letzten Jahrzehnten verändert. Gastroenterologie up2date 2022;18:192-194. [DOI: 10.1055/a-1895-8062] [Reference Citation Analysis]
22 Wang H, Gao X, Yu S, Wang W, Liu G, Jiang X, Sun D. Circular RNAs regulate parental gene expression: A new direction for molecular oncology research. Front Oncol 2022;12:947775. [DOI: 10.3389/fonc.2022.947775] [Reference Citation Analysis]
23 Cao L, Lu S, Guo C, Chen W, Gao Y, Ye D, Guo Z, Ma W. A novel electrochemical immunosensor based on PdAgPt/MoS2 for the ultrasensitive detection of CA 242. Front Bioeng Biotechnol 2022;10:986355. [DOI: 10.3389/fbioe.2022.986355] [Reference Citation Analysis]
24 Yang C, Li J, Shi J, Guo Y, Sun X, Gan D, Wang R, Zhu L, Ma P, Hua L, Yang R, Min J, Zhao T, Li S, Song Y, Su H. N6-methyladenosine modification of RanGAP1 promotes colorectal cancer progression via CRABP2.. [DOI: 10.21203/rs.3.rs-1922415/v1] [Reference Citation Analysis]
25 Li T, Liao H, Li M, Liu Y, Liang Y, Li T. Nomogram for predicting the overall survival for young-onset colorectal cancer with liver metastases: a SEER database analysis.. [DOI: 10.21203/rs.3.rs-1924954/v1] [Reference Citation Analysis]
26 Loosen SH, Schöler D, Labuhn S, Mertens A, Jördens MS, Luedde M, Kostev K, Luedde T, Roderburg C. The Spectrum of Co-Diagnoses in Patients with Colorectal Cancer: A Retrospective Cohort Study of 17,824 Outpatients in Germany. Cancers (Basel) 2022;14:3825. [PMID: 35954488 DOI: 10.3390/cancers14153825] [Reference Citation Analysis]
27 Ghadimi M, Rödel C, Hofheinz R, Flebbe H, Grade M. Multimodal Treatment of Rectal Cancer. Dtsch Arztebl Int 2022;119:570-80. [PMID: 35791271 DOI: 10.3238/arztebl.m2022.0254] [Reference Citation Analysis]
28 . The Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med 2022;387:91-4. [DOI: 10.1056/nejmc2206652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Eftekhar SP, Kazemi S, Moghadamnia AA. Effect of thymoquinone on pharmacokinetics of 5-fluorouracil in rats and its effect on human cell line in vitro. Hum Exp Toxicol 2022;41:9603271221145422. [PMID: 36510676 DOI: 10.1177/09603271221145422] [Reference Citation Analysis]
30 Chen Y, Tang L, Ye X, Chen Y, Shan E, Han H, Zhong C. Regulation of ZO-1 on β-catenin mediates sulforaphane suppressed colorectal cancer stem cell properties in colorectal cancer. Food Funct 2022. [DOI: 10.1039/d2fo02932d] [Reference Citation Analysis]